← Back to Dividend Calendar

Gilead Sciences Inc

GILDNASDAQ
HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Market Cap
$181.25B
Revenue (TTM)
$29.44B
EBITDA
$14.58B
Profit Margin
28.9%
P/E Ratio
21.57
Earnings Growth (YoY)
23.4%
Return on Equity
40.7%
Dividend Yield
2.1%

No historical dividends found for GILD.